Evidence map›Paper›PMID 31175274›Full record

ArticleTranslational psychiatry2019

Polygenic risk associated with post-traumatic stress disorder onset and severity.

Burook Misganaw, Guia Guffanti, Adriana Lori, Duna Abu-Amara, Janine D Flory, SBPBC, Susanne Mueller, Rachel Yehuda, Marti Jett, Charles R Marmar and 2 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Transcriptome-wide association study of post-trauma symptom trajectories identified GRIN3B as a potential biomarker for PTSD development.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Burook MisganawHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Guia GuffantiDepartment of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA, USA.
Adriana LoriDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
Duna Abu-AmaraSteven and Alexandra Cohen Veterans Center for the Study of Posttraumatic Stress and Traumatic Brain Injury; and Department of Psychiatry, NYU School of Medicine, New York, NY, USA.
Janine D FloryDepartment of Psychiatry, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
SBPBC
Susanne MuellerCenter for Imaging of Neurodegenerative Diseases, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Rachel YehudaDepartment of Psychiatry, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
Marti JettIntegrative Systems Biology, United States Army Medical Research and Material Command, United States Army Center for Environmental Health Research, Frederick, MD, USA.
Charles R MarmarSteven and Alexandra Cohen Veterans Center for the Study of Posttraumatic Stress and Traumatic Brain Injury; and Department of Psychiatry, NYU School of Medicine, New York, NY, USA.
Kerry J ResslerDepartment of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA, USA.
Francis J DoyleHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA. frank_doyle@seas.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-traumatic stress disorder (PTSD) is a psychiatric illness with a highly polygenic architecture without large effect-size common single-nucleotide polymorphisms (SNPs). Thus, to capture a substantial portion of the genetic contribution, effects from many variants need to be aggregated. We investigated various aspects of one such approach that has been successfully applied to many traits, polygenic risk score (PRS) for PTSD. Theoretical analyses indicate the potential prediction ability of PRS. We used the latest summary statistics from the largest published genome-wide association study (GWAS) conducted by Psychiatric Genomics Consortium for PTSD (PGC-PTSD). We found that the PRS constructed for a cohort comprising veterans of recent wars (n = 244) explains a considerable proportion of PTSD onset (Nagelkerke R

Indexed as

Genetic Predisposition to DiseaseSeverity of Illness IndexVeteransAdultBiomarkersCohort StudiesFemaleGenome-Wide Association StudyHumansMaleRiskStress Disorders, Post-TraumaticUnited StatesBiomarkers

Identifiers

PMID31175274
PMCPMC6555815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.